1. The role of PDGF-B/TGF-β1/neprilysin network in regulating endothelial-to-mesenchymal transition in pulmonary artery remodeling
    Shasha Song et al, 2016, Cellular Signalling CrossRef
  2. Activation of the FAK/PI3K pathway is crucial for AURKA-induced epithelial-mesenchymal transition in laryngeal cancer
    Liyun Yang et al, 2016 CrossRef
  3. HGF induces EMT in non-small-cell lung cancer through the hBVR pathway
    Fang Liu et al, 2017, European Journal of Pharmacology CrossRef
  4. Downregulation of Bmi-1 suppresses epithelial-mesenchymal transition in melanoma
    Yanting Liu et al, 2017 CrossRef
  5. Long non-coding RNA LINC00261 inhibits cell growth and migration in endometriosis
    Lixiao Sha et al, 2017, J. Obstet. Gynaecol. Res. CrossRef
  6. Vitamin D and renal outcome: the fourth outcome of CKD-MBD? Oshima Award Address 2015
    Takayuki Hamano, 2017, Clin Exp Nephrol CrossRef
  7. Cellular Plasticity–Targeted Therapy in Head and Neck Cancers
    W. Shang et al, 2018, J Dent Res CrossRef
  8. FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition
    Song-Lin He et al, 2018, J Cell Mol Med CrossRef
  9. Stimulation with Porphyromonas gingivalis enhances malignancy and initiates anoikis resistance in immortalized oral keratinocytes
    T. Hoppe et al, 2019, J Cell Physiol CrossRef
  10. Interleukin-7 Contributes to the Invasiveness of Prostate Cancer Cells by Promoting Epithelial–Mesenchymal Transition
    Min A. Seol et al, 2019, Sci Rep CrossRef
  11. null
    Xu Qian et al, 2019 CrossRef
  12. Influence of tumour necrosis factor alpha on epithelial–mesenchymal transition of oral cancer cells in co-culture with mesenchymal stromal cells
    F. Böhrnsen et al, 2019, International Journal of Oral and Maxillofacial Surgery CrossRef
  13. MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells.
    Peixin Dong et al, 0 CrossRef
  14. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Jiawen Xu et al, 2017, Biomed Pharmacother CrossRef
  15. null
    Daksh Thaper et al, 2019 CrossRef
  16. null
    Alexandra E. Oklejas et al, 2020 CrossRef
  17. Pin2 telomeric repeat factor 1-interacting telomerase inhibitor 1 (PinX1) inhibits nasopharyngeal cancer cell stemness: implication for cancer progression and therapeutic targeting
    Chaosheng Yu et al, 2020, J Exp Clin Cancer Res CrossRef
  18. CD36 expression on oral squamous cell carcinoma cells correlates with enhanced proliferation and migratory activity
    Kotaro Sakurai et al, 2020, Oral Dis CrossRef
  19. Apigenin inhibits NF-κB and Snail signaling, EMT and metastasis in human hepatocellular carcinoma
    Yuan Qin et al, 2106, Oncotarget CrossRef
  20. Gene‑expression signature predicts survival benefit from postoperative chemoradiotherapy in head and neck squamous cell carcinoma
    Jin Chen et al, 2018, Oncol Lett CrossRef

  21. Silenced Myeloblastosis Protein Suppresses Oral Tongue Squamous Cell Carcinoma via the microRNA-130a/Cylindromatosis Axis


    Ran Yang et al, 2020, CMAR CrossRef
  22. Snail-1 Overexpression Correlates with Metastatic Phenotype in BRAFV600E Positive Papillary Thyroid Carcinoma
    Katarzyna Wieczorek-Szukala et al, 2020, JCM CrossRef
  23. Biological Role of Epithelial–mesenchymal-transition-inducing Transcription Factors in Head and Neck Squamous Cell Carcinoma: A Systematic Review
    Everton Freitas de Morais et al, 2020, Archives of Oral Biology CrossRef
  24. The expression and clinical significance of an Epithelial-Mesenchymal Transition inducer, SNAI1, in head and neck carcinoma.
    Houyu Zhao et al, 2021, J Oral Pathol Med CrossRef
  25. Anticancer Activity of Modified Tongyou Decoction on Eca109 Esophageal Cancer Cell Invasion and Metastasis through Regulation of the Epithelial-Mesenchymal Transition Mediated by the HIF-1α-Snail Axis
    Yongsen Jia et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
  26. Epithelial‐to‐mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities
    Zihang Ling et al, 2020, Int. J. Cancer CrossRef
  27. Differences and similarities between cancer and somatic stem cells: therapeutic implications
    Fiorella Rossi et al, 2020, Stem Cell Res Ther CrossRef
  28. Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment
    Bowen Gao et al, 2021, Sci Rep CrossRef
  29. Lotus leaf extract inhibits ER− breast cancer cell migration and metastasis
    Yuelin Tong et al, 2021, Nutr Metab (Lond) CrossRef
  30. New Insights Into Oral Squamous Cell Carcinoma: From Clinical Aspects to Molecular Tumorigenesis
    Shang-Hung Chen et al, 2021, IJMS CrossRef
  31. FOSL1 promotes metastasis of head and neck squamous cell carcinoma through super-enhancer-driven transcription program
    Ming Zhang et al, 2021, Molecular Therapy CrossRef
  32. ID1 mediates resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer through epithelial–mesenchymal transition
    Kejun Liu et al, 2021, BMC Pulm Med CrossRef
  33. SALL4 stemness agent expression in oral squamous cell cancer and its clinical significance
    Abderrahman Ouban, 2021, Biotechnology & Biotechnological Equipment CrossRef
  34. Cancer drug resistance induced by EMT: novel therapeutic strategies
    Javier De Las Rivas et al, 2021, Arch Toxicol CrossRef
  35. The Role of Snail-1 in Thyroid Cancer—What We Know So Far
    Katarzyna Wieczorek-Szukala et al, 2021, JCM CrossRef
  36. Downregulation of MicroRNA-130a Inhibits Oral Squamous Cell Carcinoma Proliferation and Metastasis via the Hippo-YAP Pathway
    Yiran Peng et al, 2021, CMAR CrossRef
  37. Epithelial-Mesenchymal Transition Associated with Head and Neck Squamous Cell Carcinomas: A Review.
    Rogelio González-González et al, 2021, Cancers (Basel) CrossRef
  38. Epithelial-to-Mesenchymal Transition-Derived Heterogeneity in Head and Neck Squamous Cell Carcinomas
    Philipp Baumeister et al, 2021, Cancers CrossRef
  39. Shooting at Moving and Hidden Targets—Tumour Cell Plasticity and the Notch Signalling Pathway in Head and Neck Squamous Cell Carcinomas
    Joanna Kałafut et al, 2021, Cancers CrossRef
  40. Knockdown of long non-coding MIR210HG inhibits cell proliferation, migration, and invasion in hepatoblastoma via the microRNA-608–FOXO6 axis
    Yuhe Duan et al, 2021, J Int Med Res CrossRef
  41. Epithelial–mesenchymal transition and its transcription factors
    Pallabi Debnath et al, 2022 CrossRef
  42. Butylidenephthalide Abrogates the Snail-Induced Cancer Stemness in Oral Carcinomas
    Pei-Yin Chen et al, 2022, IJMS CrossRef
  43. HMGA2-Snai2 axis regulates tumorigenicity and stemness of head and neck squamous cell carcinoma.
    Zhongwu Li et al, 2022, Exp Cell Res CrossRef
  44. Essential role of aerobic glycolysis in epithelial-to-mesenchymal transition during carcinogenesis
    Chandra Prakash Prasad et al, 2022, Clin Transl Oncol CrossRef
  45. In vitro models for head and neck cancer: Current status and future perspective
    Christian R. Moya-Garcia et al, 2022, Front. Oncol. CrossRef
  46. Molecular Crosstalk between the Immunological Mechanism of the Tumor Microenvironment and Epithelial–Mesenchymal Transition in Oral Cancer
    Kaviyarasi Renu et al, 2022, Vaccines CrossRef
  47. The role of exosomes in the molecular mechanisms of metastasis: Focusing on EMT and cancer stem cells
    Ghader Babaei et al, 2022, Life Sciences CrossRef
  48. null
    Fernanda López-Moncada et al, 2022 CrossRef
  49. The Concept of Cancer Stem Cells: Elaborating on ALDH1B1 as an Emerging Marker of Cancer Progression
    Ilias Tsochantaridis et al, 2023, Life CrossRef
  50. YAP/TAZ activation predicts clinical outcomes in mesothelioma and is conserved in in vitro model of driver mutations.
    Richard Cunningham et al, 2023, Clin Transl Med CrossRef
  51. Serum Response Factor-Regulated IDO1/Kyn-Ahr Pathway Promotes Tumorigenesis of Oral Squamous Cell Carcinoma
    Mingyan Xu et al, 2023, Cancers CrossRef
  52. SNAIL1 is involved in the control of the epithelial-mesenchymal transition in oral tongue squamous cell carcinoma
    Everton Freitas de Morais et al, 2023, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology CrossRef
  53. SMC1A facilitates gastric cancer cell proliferation, migration, and invasion via promoting SNAIL activated EMT
    Yaling Liu et al, 2023, BMC Gastroenterol CrossRef
  54. CLDN6 Suppresses Migration and Invasion of MCF-7 and SKBR-3 Breast Cancer Cells by Blocking the SMAD/Snail/MMP-2/9 Axis
    T. Liu et al, 2023, Bull Exp Biol Med CrossRef
  55. Snail transcription factors as key regulators of chemoresistance, stemness and metastasis of ovarian cancer cells
    Michal Kielbik et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  56. Role of E-cadherin and β-catenin in head and neck squamous cell carcinoma
    A. A. Petrova et al, 2024, Sib. onkol. ž. CrossRef
  57. WNT7A promotes tumorigenesis of head and neck squamous cell carcinoma via activating FZD7/JAK1/STAT3 signaling
    Qingling Huang et al, 2024, Int J Oral Sci CrossRef
  58. Reciprocal relationship between cancer stem cells and myeloid-derived suppressor cells: implications for tumor progression and therapeutic strategies
    Guiqing Ding et al, 2024, Future Oncology CrossRef
  59. Gigaxonin Suppresses Epithelial-to-Mesenchymal Transition of Human Cancer Through Downregulation of Snail
    Mysore S. Veena et al, 2024 CrossRef
  60. MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative Breast Cancer Metastases
    Koichi Ito et al, 2024 CrossRef